Ml. Cunningham et Ah. Fairlamb, TRYPANOTHIONE REDUCTASE FROM LEISHMANIA-DONOVANI - PURIFICATION, CHARACTERIZATION AND INHIBITION BY TRIVALENT ANTIMONIALS, European journal of biochemistry, 230(2), 1995, pp. 460-468
Trypanothione reductase was purified to homogeneity from Leishmania do
novani promastigotes transfected with the expression plasmid pTEX-LdTR
. The physical, spectral and kinetic properties were found to be simil
ar to those obtained from other pathogenic trypanosomatids. The substr
ates trypanothione disulfide and NADPH exhibit Michaelis-Menten satura
tion kinetics with K-m values of 36 mu M and 9 mu M, respectively, the
former yielding a k(cat)/K-m of 5.0X10(6) M(-1) s(-1). Like other try
panothione reductases, the leishmania enzyme is unable to use glutathi
one disulfide as substrate. Both trypanothione reductase and the analo
gous mammalian enzyme, glutathione reductase, are inhibited by trivale
nt but not pentavalent anti-leishmanial antimonials. Inhibition by tri
valent sodium antimonyl gluconate (Triostam) occurs in a time-dependen
t manner, with the pseudo-first-order rate constants of inhibition bei
ng linearly related to drug concentration. Inhibition proceeds until a
n apparent equilibrium between active enzyme/free drug and inactive en
zyme-drug complex is reached. MelT, an adduct of melarsen oxide and di
hydrotrypanothione which is a competitive inhibitor of the disulfide b
inding site of trypanothione reductase, confers protection against Tri
ostam. Prior reduction of the catalytically active disulfide bridge by
NADPH is essential for inhibition. Spectral analysis shows that the b
road absorbance band centred on 530 nm, characteristic of the charge-t
ransfer complex in the two-electron-reduced EH, enzyme, is lost upon a
ddition of Triostam. Further spectral changes resemble those associate
d with reduction of the FAD prosthetic group to FADH(2). Inhibition by
Triostam is readily reversed by dilution or addition of the dithiols
2,3-dimercaptopropanol, 2,3-dimercaptosuccinate or dithiothreitol, but
not dihydrotrypanothione, suggesting that this trypanosomatid-unique
metabolite is unlikely to protect the enzyme from inhibition in whole
cells. A mechanism consistent with these observations is proposed.